Premium Information is available for this item - Upgrade for $1 a day
6505-01-374-5867
Ondansetron Hydrochloride Tablets
6505013745867 013745867 ZOFRAN ZOFRAN TABLETS NDC00173-0446-02
INC: 49831 Ondansetron Hydrochloride Tablets
Managed by United States
NSN Created on 26 Apr 1993
Data Last Changed
November 2023
November 2023
NATO Update Count
8
8
NATO Data Quality
Marketplace 6505-01-374-5867
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-374-5867 5+ Documents (More...)
ZOFRAN ZOFRAN TABLETS NDC00173-0446-02 Managed by United States NSN Created on 26 Apr 1993 Data Last
TABLETS https//www.nsnlookup.com /fsg-65/ Secondary Reference RNCC 5 RNVC 1 DAC 4 ZOFRAN TABLETS uk
RNCC 5 RNVC 1 DAC 4 ZOFRAN TABLETS uk 6505-99-740-0546 TABLETSNDC00173-0446-02 Managed by United States
TABLETS https//www.nsnlookup.com /fsg-65/ Secondary Reference RNCC 5 RNVC 1 DAC 4 ZOFRAN TABLETS uk
RNCC 5 RNVC 1 DAC 4 ZOFRAN TABLETS uk 6505-99-740-0546 TABLETSNDC00173-0446-02 Managed by United States
ZOFRAN TABLETS NDC00173-0446-04 Managed by United States NSN Created on 26 Apr 1993 Data Last Changed
Ondansetron Hydrochloride Tablets 013745867 Apr 1993 Data Last 5 RNVC 1 DAC 4 ZOFRAN ZOFRAN TABLETS
Ondansetron Hydrochloride Tablets 013745867 ZOFRAN TABLETS NDC00173-0446-02 Managed by United States
Ondansetron Hydrochloride Tablets 013745867 Apr 1993 Data Last 5 RNVC 1 DAC 4 ZOFRAN ZOFRAN TABLETS
Ondansetron Hydrochloride Tablets 013745867 ZOFRAN TABLETS NDC00173-0446-02 Managed by United States
Ondansetron Hydrochloride Tablets 013745867 RNCC 5 RNVC 1 DAC 4 ZOFRAN TABLETS uk 6505-99- https
997400546 6505-43- https https//www.nsnlookup.com /fsg-65/ Secondary Reference RNCC 5 RNVC 1 DAC 4 ZOFRAN
65/fsc-6505/uk 6505-99-740-0546 Ondansetron Hydrochloride Tablets 997400546 Hydrochloride Tablets 013745867
997400546 6505-43- https https//www.nsnlookup.com /fsg-65/ Secondary Reference RNCC 5 RNVC 1 DAC 4 ZOFRAN
65/fsc-6505/uk 6505-99-740-0546 Ondansetron Hydrochloride Tablets 997400546 Hydrochloride Tablets 013745867
enable JavaScript in your web browser . 6505-99-899-7179Ondansetron Hydroch6505998997179 998997179 ZOFRAN
Tablets6505013745867 013745867 ZOFRAN ZOFRAN TABLETS https//www.nsnlookup.com /fsg-65/ Secondary Reference
RNCC 5 RNVC 1 DAC 4 ZOFRAN TABLETS uk 6505-99- https https//www.nsnlookup.com /fsg-65/fsc-6505/uk 6505
Tablets6505013745867 013745867 ZOFRAN ZOFRAN TABLETS https//www.nsnlookup.com /fsg-65/ Secondary Reference
RNCC 5 RNVC 1 DAC 4 ZOFRAN TABLETS uk 6505-99- https https//www.nsnlookup.com /fsg-65/fsc-6505/uk 6505
enable JavaScript in your web browser . 6505-99-899-7281Glibenclamide Table6505998997281 998997281 ZOFRAN
013745867 Account Upgrade 6505-01-374-5867Ondansetron Hydrochloride Tablets6505013745867 013745867 ZOFRAN
1 DAC 4 ZOFRAN TABLETS https//www.nsnlookup.com /fsg-65/ Secondary Reference RNCC 5 RNVC 1 DAC 4 ZOFRAN
013745867 Account Upgrade 6505-01-374-5867Ondansetron Hydrochloride Tablets6505013745867 013745867 ZOFRAN
1 DAC 4 ZOFRAN TABLETS https//www.nsnlookup.com /fsg-65/ Secondary Reference RNCC 5 RNVC 1 DAC 4 ZOFRAN
Restrictions 6505-01-374-5867
6505-01-374-5867 is a Ondansetron Hydrochloride Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item has been determined to be hazardous and information is contained in the Hazardous Materials Information Resource System (HMIRS). This item does not contain a precious metal.
Approved Sources 6505-01-374-5867
- Part Number
- Manufacturer
- Status
- NDC00173-0446-02
- Manufacturer
- 34006 - Glaxo Wellcome Inc (Active)
- Primary Buy
- Primary Buy
- ZOFRAN
- 34006 - Glaxo Wellcome Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- ZOFRAN TABLETS
- 34006 - Glaxo Wellcome Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Management Data 6505-01-374-5867
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Mar 2002
- Department of the Army (DA)
- PG
- Subscribe
- 1
- PG
- Dec 2001
- Department of the Navy (DN)
- PG
- Subscribe
- 1
- PG
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Department of the Navy (DN)
- N
- K
- U/I Contains 100 Tt
- 00000000100TT
- K
- Department of the Navy (DN)
- N
- V
- Discontinued Without Replacement
- V
Army
- Materiel Category and Inventory Manager:
- C
- Medical/Dental Materiel
- Appropriation and Budget Activity:
- 2
- Stock Fund Secondary Items
- Management Inventory Segment:
- 2
- Non-Repairable Items(Exclusive of Insurance and Provisioning Items)
This code will be used to identify items, which are not reparable.
- Weapons System / End Item / Homogeneous Group:
- 01
- DLA/GSA Material
Type 1 (Non-Extendable) Potency Dated Item
- Accounting Requirements:
- X
- Expendable item.An item of Army property coded with an ARC of X in the AMDF. Expendable items require no formal accountability after issue from a stock record account.Commercial and fabricated items similar to items coded X in the AMDF are considered expendable items.
Navy
- Cognizance:
- 9L
Similar Supply Items to 6505-01-374-5867
